إعلان
إعلان

PRVA

PRVA logo

Privia Health Group, Inc. Common Stock

24.14
USD
برعاية
+0.68
+2.88%
٠٥ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

قبل الإفتتاح

23.98

-0.16
-0.66%

تقارير أرباح PRVA

النسبة الإيجابية المفاجئة

PRVA تفوق 9 من 19 آخر التقديرات.

47%

التقرير التالي

بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$838.94M
/
$0.03
التغير الضمني من Q3 25 (Revenue/ EPS)
-10.79%
/
-40.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+5.86%
/
--

Privia Health Group, Inc. Common Stock earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, PRVA reported earnings of 0.05 USD per share (EPS) for Q3 25, missing the estimate of 0.05 USD, resulting in a -8.93% surprise. Revenue reached 940.40 مليون, compared to an expected 797.58 مليون, with a 17.91% difference. The market reacted with a -4.16% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 21 المحللين forecast an EPS of 0.03 USD, with revenue projected to reach 838.94 مليون USD, implying an نقصان of -40.00% EPS, and نقصان of -10.79% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Privia Health Group, Inc. Common Stock reported EPS of $0.05, missing estimates by -8.93%, and revenue of $940.40M, 17.91% above expectations.
The stock price moved down -4.16%, changed from $25.02 before the earnings release to $23.98 the day after.
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
Based on 21 المحللين, Privia Health Group, Inc. Common Stock is expected to report EPS of $0.03 and revenue of $838.94M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان